Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-06-03
1986-07-01
Lesmes, George F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548229, 548232, C07D26324, A61K 3142
Patent
active
045980845
ABSTRACT:
N-arylated oxazolidine-2-one derivatives corresponding to the formula: ##STR1## and of S(+) configuration, A representing in this case the hydroxyl radical or of R (+) configuration, A designating then the N-methylamino group, as well as the acid addition salts thereof.
Application in therapeutics more particularly as monoamine oxidase inhibitors.
REFERENCES:
patent: 4287351 (1981-09-01), Bourgery et al.
Dostert, P. et al., Chem. Abst., 98:46460b (1983).
Strolin Benedetti; M. et al., Chem. Abst., 98:46837e (1983).
Int. Congr. Ser. - Excerpta Med. 1982, 564 Monoamine Oxidase), 197-208.
Int. Congr. Ser. - Excerpta Med. 1982, 564 (Monoamine Oxidase), 209-220.
Dostert Philippe L.
Guerret Patrick G.
Langlois Michel
Strolin-Benedetti Margherita
Delalande S.A.
Gibson S. A.
Lesmes George F.
LandOfFree
Optically active derivatives of N-arylated oxazolidine-2-one, th does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optically active derivatives of N-arylated oxazolidine-2-one, th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically active derivatives of N-arylated oxazolidine-2-one, th will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1082745